Sphingolipid Biosynthesis, Metabolism and Actions in Placental Trophoblast Differentiation
Total Page:16
File Type:pdf, Size:1020Kb
Sphingolipid biosynthesis, metabolism and actions in placental trophoblast differentiation Ambika Singh BSc, MSc (Hons) This thesis is presented in 2012 for the degree of DOCTOR OF PHILOSOPHY (PhD) Of The University of Western Australia, School of Women’s and Infants’ Health, Faculty of Medicine, Dentistry and Health Sciences & School of Anatomy and Human Biology, Faculty of Life and Physical Sciences i ABSTRACT Formation and maintenance of the syncytiotrophoblast layer of the human placenta involves the fusion and terminal differentiation of trophoblast cells, the specialized cell type of the placenta. This process is unique and although it has been actively investigated over recent years, it remains incompletely understood. Sphingolipids such as sphingosine and ceramide are important endogenous cellular components which are controlled at the level of synthesis, metabolism and distribution, and act as regulators of numerous cellular functions including apoptosis and differentiation. The role of sphingolipids in trophoblast apoptosis, differentiation and fusion has not been elucidated in detail, apart from a study by Johnstone et al. indicating a negative role of sphingosine-1-phosphate (S1P) in this process. A previous work from our laboratory also implicated a role for ceramide in this process. The aim of this project, therefore, was to examine the production, metabolism and actions of key sphingolipids - ceramide, sphingosine and S1P - during spontaneous trophoblast differentiation in vitro to determine their role(s) in the differentiation process. Since earlier findings in a cell line model had shown an association between intracellular levels of ceramide and the lipid transporter ABCG2 (also known as breast cancer resistance protein, BCRP), I also investigated the putative link between ABCG2 function, sphingolipid levels and trophoblast differentiation. I established a model of syncytialization, adapted from previously published methods, using human cytotrophoblasts extracted from term placentas syncytialized over 7 days in culture. Characterization of this model showed that patterns of expression/production differentiation markers – human chorionic gonadotrophin (hCG), alkaline phosphatase and GCM1 – varied during the differentiation process and that differentiation and cell fusion were independent processes. Lipids were extracted during the differentiation process and analysed by liquid chromatography- mass spectrometry. Intracellular C16 ceramide levels increased modestly after 3 days in culture then declined to basal levels, accompanied by changes in expression of ceramide synthesizing (sphingomyelinase, ceramide synthase) and degrading (ceramidase) enzymes. Ceramidase was present at particularly high levels in syncytialized trophoblasts; inhibition of ceramidase reduced the degree of cell fusion, suggesting i that this enzyme may be involved in maintaining the syncytial phenotype. Exposure of trophoblasts for 72 h to short chain C8 ceramide or sphingomyelinase to increase cellular levels of ceramide enhanced secretion of the differentiation marker hCG without affecting fusion or cell viability. In contrast to ceramide, significant declines in intracellular sphingosine levels and protein levels of sphingosine kinase 1 (SPHK1, the rate-limiting enzyme for S1P production) were observed during trophoblast differentiation and fusion. Secreted S1P levels dropped steeply while hCG secretion levels and levels of intraceullular ceramide were maximum, before rising back to basal levels with syncytialization. Intracellular S1P levels were undetectable. Treating cells with either exogenous sphingosine, S1P or a specific SPHK1 inhibitor for up to 72 h in culture significantly inhibited trophoblast differentiation (measured as reduced hCG production); effects on other biochemical and morphological markers of differentiation were absent or inconsistent. Inhibition of the ceramide- and S1P-responsive pathways, namely c-Jun N-terminal kinase (JNK), protein phosphatase 2A (PP2A), p38MAPK, phosphatidylinositol 3- kinase (PI3K) and ERK1/2 did not abolish the effects of these bioactive mediators, and JNK phosphorylation was unresponsive to these compounds. However, novel roles of protein kinase B (PKB)/Akt, a growth and differentiation factor, and JNK in trophoblast differentiation and fusion were identified in this study as indicated by spontaneous changes in their phosphorylation state with syncytialisation. Ceramide and S1P significantly inhibited phosphorylation of Akt, suggesting that this may be a novel mechanism through which trophoblast differentiation may be regulated by sphingolipids. Overall, my findings suggest that changes in ceramide biosynthesis and metabolism play a significant role in modulating the biochemical and morphological features of trophoblast differentiation. The data support the notion that at least some aspects of trophoblast differentiation and fusion can be dissociated as indicated by the differences in response between morphological and biochemical differentiation markers. My finding that ceramide is an intracellular regulator able to exert differential effects on functional trophoblast differentiation and syncytialization raises questions regarding the significance of ceramide synthesis and metabolism in abnormal pregnancies. ii These studies did not confirm the expected association between sphingolipids (ceramide and sphingosine-1-phosphate) and ABCG2 during trophoblast differentiation and syncytialization, and hence do not support a role for ABCG2 in trophoblast differentiation in the human placenta, in contrast to findings previously reported using the BeWo choriocarcinoma cell line. In conclusion, the principal findings of this thesis suggest that sphingolipid homeostasis is regulated during trophoblast differentiation and fusion and that its dysregulation could result in defects in placental formation and function. Disturbances in sphingolipid homeostasis could, therefore, have deleterious consequences for pregnancy outcome and fetal well being, as seen in pregnancy complications such as preeclampsia which are characterized by aberrant placental syncytialization. iii ACKNOWLEDGMENTS I am extremely grateful to my supervisor Professor Jeff Keelan, whose patience, kindness, and academic expertise, have been invaluable to me. His compassionate support and constant guidance helped my thesis through to completion. An excellent mentor and role model. Studying in his group provided a brilliant training platform, offering a varied range of opportunities and developmental skills. I am heartily thankful to my co-supervisor Professor Arun Dharmarajan, whose encouragement, guidance and support from the onset to the final level enabled me to develop an understanding of the subject and opening several networking opportunities. The School of Women’s and Infants’ Health provided remarkable study and lab facilities with a bonus exceptional team to work with. I would like to thank the funding support of the Women’s and Infants’ Research Foundation (WIRF) at King Edward Memorial Hospital, University of Western Australia, Perth, and the Liggins Institute, University of Auckland, New Zealand. I would like to thank Sonia Alix, Eric Thorstensen and Thomas Stoll for carrying out the challenging sphingolipid mass spectrometry assays successfully with utmost proficiency. The intellectual support and feedback provided by fellow PhD student Irving Aye, is truly appreciated. His generosity and friendship contributed significantly towards completion and submission of this thesis. Other colleagues I would like to thank for their guidance include Biju Balakrishna, Denis Evseenko and Vijay Pandey. I am indebted to my friends, Disha Saxena, Parul Chauhan and Kirthana Prabhakaran, for providing constant encouragement and motivation. Ronak Sampat, for making a sterling effort in proof reading my thesis (coming from a non- science background). I am eternally grateful for the continuous motivation in making me strive for excellence and give this thesis my best shot. Thanks for having an enormous amount of faith in me, the invaluable words of wisdom and referral to value-adding books. I owe my deepest gratitude to my beloved parents and brother, Pranay Singh. This thesis would not be possible minus their constant source of support. My pillar of strength, joy and guiding light. Thank you very much for creating an environment in which following this path seemed so natural, and for having tremendous patience. iv ACHIEVEMENTS DURING PhD Manuscripts and abstracts arising from this thesis 1. AT Singh, A Dharmarajan, ILMH Aye, JA Keelan. Role of ceramide biosynthesis and metabolism in the regulation of trophoblast differentiation and syncytialisation. Molecular and Cellular Endocrinology. In revision. 2. AT Singh, A Dharmarajan, ILMH Aye, JA Keelan. The Sphingosine-S1P pathway regulates trophoblast differentiation and syncytialization. Reproductive BioMedicine Online. 24: 224– 234. 3. A Al-Khan, ILMH Aye, AT Singh, et al.: IFPA Meeting 2010 Workshops Report II: Placental pathology; Trophoblast invasion; Fetal sex; Parasites and the placenta; Decidua and embryonic or fetal loss; Trophoblast differentiation and syncytialization. Placenta. Placenta. 2011; 32 (2): S90-S99. 4. AT Singh and JA Keelan: Faculty of 1000 Biology, 22 Apr 2010 http://f1000biology.com/article/id/3001967/evaluation. 5. AT Singh and JA Keelan: Faculty of 1000 Biology, 21 Apr 2010 http://f1000biology.com/article/id/2982958/evaluation. 6. AT Singh, ILMH Aye, JA Keelan.